Suraksha Diagno.

{
  "main_header": {
    "sid": 10039467,
    "name": "Suraksha Diagno.",
    "stock_name": "Suraksha Diagno.",
    "full_name": "Suraksha Diagnostic Ltd",
    "name_url": "stocks-analysis/suraksha-diagno",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "285.10",
    "chg": -3.85,
    "chgp": "-1.33%",
    "dir": -1,
    "prev_price": "288.95",
    "mcapval": "1,502.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544293,
    "symbol": "SURAKSHA",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE877V01027",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "15.76 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/suraksha-diagno-10039467-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Suraksha Diagnostic Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-suraksha-diagnostic-ltd-latest-results-good-or-bad-3824969",
        "imagepath": "",
        "date": "2026-02-06 19:31:42",
        "description": "Suraksha Diagnostic Ltd's latest financial results for Q2 FY26 reveal a complex operational landscape characterized by contrasting trends in revenue and profitability. The company reported net sales of ₹78.73 crores, reflecting a year-on-year growth of 17.95% and a sequential increase of 8.46%. This indicates robust demand for its diagnostic services, suggesting that the company is effectively capturing market share.\n\nHowever, the net profit for the same quarter was ₹8.99 crores, which represents a decline of 13.06% year-on-year. This decline in profit is concerning, particularly as it coincides with a significant contraction in operating margins, which fell to 30.62% from 34.74% a year earlier. The operating profit margin has also decreased sequentially, indicating ongoing pressure on profitability despite the revenue growth.\n\nThe company's return on equity (ROE) stands at 13.86%, which, while positive, su..."
      },
      {
        "title": "Suraksha Diagnostic Q2 FY26: Margin Pressure Weighs on Bottom Line Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/suraksha-diagnostic-q2-fy26-margin-pressure-weighs-on-bottom-line-despite-revenue-growth-3823054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SurakshaDiagnos_quaterlyResult_3823054.png",
        "date": "2026-02-05 19:35:23",
        "description": "Suraksha Diagnostic Limited, a Kolkata-based diagnostic services provider, reported a consolidated net profit of ₹8.99 crores for Q2 FY26, marking a sequential decline of 4.36% from ₹9.40 crores in Q1 FY26 and a year-on-year contraction of 13.06% from ₹10.34 crores in Q2 FY25. The company's market capitalisation stands at ₹1,485 crores, positioning it as a small-cap player in India's healthcare services sector. Despite robust revenue growth of 17.95% year-on-year, deteriorating operating margins and elevated interest costs continue to constrain profitability, raising concerns about the sustainability of earnings quality in an increasingly competitive diagnostic landscape."
      },
      {
        "title": "Why is Suraksha Diagnostic Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-suraksha-diagnostic-ltd-fallingrising-3819402",
        "imagepath": "",
        "date": "2026-02-04 01:26:43",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Short-Term Performance Against Market Benchmarks</strong></p>\n<p>Suraksha Diagnostic Ltd has demonstrated impressive returns over recent periods, particularly when compared to the Sensex. Over the past week, the stock gained 10.55%, significantly outpacing the Sensex’s 2.30% rise. Similarly, the one-month return of 3.08% contrasts with the Sensex’s decline of 2.36%, while year-to-date gains stand at 6.64% against the benchmark’s negative 1.74%. These figures underscore the stock’s resilience and growing investor confidence in the near term, despite a one-year return of -8.38% which lags behind the Sensex’s 8.49% growth.</p>\n<p><strong>Investor Participation and Liquidity Driving Momentum</strong></p>\n<p>One of the key drivers behind the recent price appreciation is the marked increase..."
      },
      {
        "title": "Suraksha Diagnostic Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suraksha-diagnostic-ltd-is-rated-hold-3816225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SurakshaDiagnos_mojoScore_3816225.png",
        "date": "2026-02-02 10:10:47",
        "description": "Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 02 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market performance."
      },
      {
        "title": "Suraksha Diagnostic Ltd Valuation Shifts Signal Fair Price Amid Healthcare Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suraksha-diagnostic-ltd-valuation-shifts-signal-fair-price-amid-healthcare-sector-dynamics-3813821",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SurakshaDiagnos_valuationdot_3813821.png",
        "date": "2026-02-01 08:07:26",
        "description": "Suraksha Diagnostic Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade, reflecting evolving investor sentiment amid a competitive healthcare services sector. Despite a recent upgrade in its mojo grade from Sell to Hold, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more cautious outlook compared to its historical averages and peer group benchmarks."
      },
      {
        "title": "Suraksha Diagnostic Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suraksha-diagnostic-ltd-is-rated-hold-3799876",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SurakshaDiagnos_mojoScore_3799876.png",
        "date": "2026-01-22 10:10:41",
        "description": "Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 22 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Suraksha Diagnostic Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suraksha-diagnostic-ltd-is-rated-hold-3788801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SurakshaDiagnos_mojoScore_3788801.png",
        "date": "2026-01-11 10:10:27",
        "description": "Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Suraksha Diagnostic Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suraksha-diagnostic-ltd-is-rated-hold-3776095",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SurakshaDiagnos_mojoScore_3776095.png",
        "date": "2025-12-31 10:10:03",
        "description": "Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Suraksha Diagno. Sees Revision in Market Assessment Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suraksha-diagno-upgraded-from-sell-to-hold-by-marketsmojo-on-11-aug-2025-3764475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SurakshaDiagno_mojoScore_3764475.png",
        "date": "2025-12-20 10:10:25",
        "description": "Suraksha Diagno., a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key financial and technical parameters. Despite ongoing challenges in stock performance, certain fundamental aspects have prompted a reassessment of the company’s standing among investors and analysts."
      }
    ],
    "total": 94,
    "sid": "10039467",
    "stock_news_url": "https://www.marketsmojo.com/news/suraksha-diagnostic-10039467"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "06-Feb-2026",
      "details": "The audio recording of the Earnings Call held today i.e. Friday 06 February 2026 at 2.30 pm on the interaction of the Companys representative with Analyst(s) /Investor(s) on the unaudited (standalone and consolidated) financial results for the quarter and nine months ended 31 December 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Feb-2026",
      "details": "Newspaper publication of unaudited (standalone and consolidated) financial results for quarter and nine months ended 31 December 2025",
      "source": "BSE"
    },
    {
      "caption": "Financial Results Of The Company For The Quarter And Nine Months Ended 31 December 2025 Along With The Limited Review Report.",
      "datetime": "05-Feb-2026",
      "details": "Financial Results of the Company for the quarter and nine months ended 31 December 2025 along with the Limited Review Report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Suraksha Diagnostic Ltd latest results good or bad?

2026-02-06 19:31:42

Suraksha Diagnostic Ltd's latest financial results for Q2 FY26 reveal a complex operational landscape characterized by contrasting trends in revenue and profitability. The company reported net sales of ₹78.73 crores, reflecting a year-on-year growth of 17.95% and a sequential increase of 8.46%. This indicates robust demand for its diagnostic services, suggesting that the company is effectively capturing market share. However, the net profit for the same quarter was ₹8.99 crores, which represents a decline of 13.06% year-on-year. This decline in profit is concerning, particularly as it coincides with a significant contraction in operating margins, which fell to 30.62% from 34.74% a year earlier. The operating profit margin has also decreased sequentially, indicating ongoing pressure on profitability despite the revenue growth. The company's return on equity (ROE) stands at 13.86%, which, while positive, su...

Read full news article

Suraksha Diagnostic Q2 FY26: Margin Pressure Weighs on Bottom Line Despite Revenue Growth

2026-02-05 19:35:23

Suraksha Diagnostic Limited, a Kolkata-based diagnostic services provider, reported a consolidated net profit of ₹8.99 crores for Q2 FY26, marking a sequential decline of 4.36% from ₹9.40 crores in Q1 FY26 and a year-on-year contraction of 13.06% from ₹10.34 crores in Q2 FY25. The company's market capitalisation stands at ₹1,485 crores, positioning it as a small-cap player in India's healthcare services sector. Despite robust revenue growth of 17.95% year-on-year, deteriorating operating margins and elevated interest costs continue to constrain profitability, raising concerns about the sustainability of earnings quality in an increasingly competitive diagnostic landscape.

Read full news article

Why is Suraksha Diagnostic Ltd falling/rising?

2026-02-04 01:26:43

Strong Short-Term Performance Against Market Benchmarks

Suraksha Diagnostic Ltd has demonstrated impressive returns over recent periods, particularly when compared to the Sensex. Over the past week, the stock gained 10.55%, significantly outpacing the Sensex’s 2.30% rise. Similarly, the one-month return of 3.08% contrasts with the Sensex’s decline of 2.36%, while year-to-date gains stand at 6.64% against the benchmark’s negative 1.74%. These figures underscore the stock’s resilience and growing investor confidence in the near term, despite a one-year return of -8.38% which lags behind the Sensex’s 8.49% growth.

Investor Participation and Liquidity Driving Momentum

One of the key drivers behind the recent price appreciation is the marked increase...

Read full news article

Suraksha Diagnostic Ltd is Rated Hold

2026-02-02 10:10:47

Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 02 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market performance.

Read full news article

Suraksha Diagnostic Ltd Valuation Shifts Signal Fair Price Amid Healthcare Sector Dynamics

2026-02-01 08:07:26

Suraksha Diagnostic Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade, reflecting evolving investor sentiment amid a competitive healthcare services sector. Despite a recent upgrade in its mojo grade from Sell to Hold, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more cautious outlook compared to its historical averages and peer group benchmarks.

Read full news article

Suraksha Diagnostic Ltd is Rated Hold

2026-01-22 10:10:41

Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 22 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

Suraksha Diagnostic Ltd is Rated Hold

2026-01-11 10:10:27

Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Suraksha Diagnostic Ltd is Rated Hold

2025-12-31 10:10:03

Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Suraksha Diagno. Sees Revision in Market Assessment Amidst Mixed Financial Signals

2025-12-20 10:10:25

Suraksha Diagno., a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key financial and technical parameters. Despite ongoing challenges in stock performance, certain fundamental aspects have prompted a reassessment of the company’s standing among investors and analysts.

Read full news article

View All News